إعلان
إعلان
KROS
Keros Therapeutics, Inc. Common Stock
19.19
USDبرعاية
+0.61
+3.29%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
18.96
-0.23
-1.21%
تقارير أرباح KROS
النسبة الإيجابية المفاجئة
KROS تفوق 14 من 23 آخر التقديرات.
61%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$2.81M
/-$0.60
التغير الضمني من Q3 25 (Revenue/ EPS)
-80.28%
/+233.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
-7.55%
/-46.90%
Keros Therapeutics, Inc. Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, KROS reported earnings of -0.18 USD per share (EPS) for Q3 25, beating the estimate of -1.06 USD, resulting in a 83.14% surprise. Revenue reached 14.26 مليون, compared to an expected 3.88 مليون, with a 267.96% difference. The market reacted with a +3.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 المحللين forecast an EPS of -0.60 USD, with revenue projected to reach 2.81 مليون USD, implying an زيادة of 233.33% EPS, and نقصان of -80.28% in Revenue from the last quarter.
الأسئلة الشائعة
What were Keros Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Keros Therapeutics, Inc. Common Stock reported EPS of -$0.18, beating estimates by 83.14%, and revenue of $14.26M, 267.96% above expectations.
How did the market react to Keros Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.32%, changed from $15.65 before the earnings release to $16.17 the day after.
When is Keros Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Keros Therapeutics, Inc. Common Stock's next earnings report?
Based on 12
المحللين, Keros Therapeutics, Inc. Common Stock is expected to report EPS of -$0.60 and revenue of $2.81M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان